Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen blood cell disorder drug meets primary goal in phase 3 trial
Amgen blood cell disorder drug meets primary goal in phase 3 trial
Amgen blood cell disorder drug meets primary goal in phase 3 trial
Submitted by
admin
on February 16, 2016 - 10:01am
Source:
Yahoo/Reuters
News Tags:
Amgen
Aranesp
MDS
clinical trials
Headline:
Amgen blood cell disorder drug meets primary goal in phase 3 trial
Do Not Allow Advertisers to Use My Personal information
